UNITED STATES
SECURITIES AND
EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to
Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 25, 2011
ULTRALIFE
CORPORATION
(Exact name of registrant as
specified in its charter)
Delaware | 000-20852 | 16-1387013 | ||
(State or other Jurisdiction of Incorporation) | (Commission File Number) | (IRS Employer Identification No.) |
2000 Technology Parkway,
Newark, New York |
14513 | |
(Address of Principal Executive Offices) | (Zip Code) |
Registrant’s telephone number, including area code: (315) 332-7100
(Former name or former address if changed since last report.) |
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written
communications pursuant to Rule 425 under the Securities Act (17 CFR
230.425)
o Soliciting material pursuant
to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule
14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule
13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Exhibit | ||
Number | Description | |
10.1
|
Revised Definition of Change in Control for the Ultralife Restated LTIP |
Date: May 26, 2011 | ULTRALIFE CORPORATION |
|||
By: | /s/ Peter F. Comerford | |||
Peter F. Comerford | ||||
Vice President of Administration, General Counsel and Secretary | ||||
Exhibit | ||
Number | Description | |
10.1
|
Revised Definition of Change in Control for the Ultralife Restated LTIP |